[Assessment of different homeostatic methods used in laparoscopic intramural myomectomy]

Zhonghua Yi Xue Za Zhi. 2008 Apr 1;88(13):905-8.
[Article in Chinese]

Abstract

Objective: To explore the safe and effective method of hemostasis in laparoscopic hysteromyomectomy (LM).

Methods: Two hundred and eighty women with symptomatic uterine intramural fibroids undergoing LM were assigned to 4 groups, Group A undergoing fibroid pedicle ligation, Group B injected with 12 IU diluted vasopressin around the myoma, Group C injected with 20 IU oxytocin combined with pedicle ligation, and Group D injected with vasopressin combined with pedicle ligation. The operation time, amount of blood loss, operative complications, bowel deflation, post-operative hemoglobin dropping, and length of hospital stay were compared.

Results: The amounts of blood loss of Groups A and C were (171 +/- 146) ml and (184 +/- 140) ml, both significantly higher than those of Groups B and D [(115 +/- 70) ml and (106 +/- 73) ml, both P < 0.01]. The length of hospital stay of Group D was (2.9 +/- 0.5) d, significantly shorter than those of Groups A, B, and C [(3.1 +/- 0.7) d, (3.6 +/- 0.8) d, and (3.3 +/- 0.7) d, all P < 0.05]. The bowel deflation time of Group D was (20 +/- 6) h, significantly shorter than those of the Groups A, B, and C [(26 +/-) h, (25 +/- 7) h, and (25 +/- 8) h respectively, all P < 0.05]. The post-operative hemoglobin dropping of group D was (1.1 +/- 0.9) g/L, significantly less than those of Groups A, B, and C [(1.5 +/- 1.0), (1.4 +/- 0.8), and (1.2 +/- 0.7) g/L respectively, all P < 0.05].

Conclusions: Vasopressin (12 IU) injection around the myoma is a simple, effective, and safe homeostatic procedure during LM. Pedicle ligation can reduce advanced post-operative bleeding post-operation.

Publication types

  • English Abstract
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Female
  • Gynecologic Surgical Procedures / methods*
  • Hemostatic Techniques
  • Hemostatics / administration & dosage
  • Hemostatics / therapeutic use
  • Humans
  • Laparoscopy
  • Leiomyoma / therapy*
  • Myoma / therapy
  • Oxytocics / administration & dosage
  • Oxytocics / therapeutic use
  • Oxytocin / administration & dosage
  • Oxytocin / therapeutic use*
  • Postoperative Hemorrhage / prevention & control
  • Treatment Outcome
  • Uterine Neoplasms / therapy*
  • Vasopressins / administration & dosage
  • Vasopressins / therapeutic use*

Substances

  • Hemostatics
  • Oxytocics
  • Vasopressins
  • Oxytocin